Bone Quantitative Ultrasound (QUS) was primarily employed 25 years ago by Langton to study physical and chemical properties of bones. After an early period of great widespread, employment of QUS has encountered difficulties on daily clinical applications.
Chronic kidney disease (CKD) is a pathophysiologic process characterized by progressive loss of nephrons and function due to multiple etiologies and frequently leading to end stage renal disease (ESRD).
As other ultrasound devices, echocardiography holds three fundamental advantages in managing ultrasound imaging: no needs of invasive techniques, good cost/effectiveness ratio and wide staircase available technology. Ultrasound echocardiographic application needs micro-convex probes from 3-3.5 MHz.
Nephrolithiasis is an independent risk factor for the development of chronic kidney disease (CKD) in patients with nephrolithiasis. The causative relationship between the two is known for sometimes, however, factors responsible are better characterized now.
A reliable vascular access is crucial in providing life sustaining dialysis therapies in patients with End Stage Renal Disease (ESRD). An access that is easy to create, readily available for usage and relatively maintenance free with a low infection risk is considered an “ideal” vascular access.
Acute renal failure, (ARF) is a rapid loss of kidney function and represents an increasingly common and potentially catastrophic complication in hospitalized patients.
Ultrasound (US) imaging is a reliable, safe, portable, and usually easily accessible technology which is widely used in the work up of diseases of the kidneys and bladder.
The use of ultrasonography in dialysis patients is primarily a modality for diagnosis of dialysis access complications and infections. The noninvasive nature of the modality and the avoidance of contrast agents helps eliminate the need for IV access which is often limited and preservation of residual renal function in comparison to CT imaging.